2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
22
Gastrointestinal
21
Thoracic
14
Breast
14
Lymphoid
12
Head & Neck
12
Endocrine
11
Tumor-Agnostic
10
NET
9
Gynecologic
7
CNS
7
Other hematologic neoplasm
6
Plasma cell
5
Sarcoma
1
Dermatologic
1
Classical hematology
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Osteosarcoma
1
Mouth Neoplasms
1
Interventions
Radiotherapy
221
Cyclophosphamide
211
Doxorubicin
210
Temozolomide
182
Ifosfamide
121
Filgrastim
111
Imatinib Mesylate
104
Etoposide
101
Vincristine
92
Gemcitabine
89
Bevacizumab
83
Magnetic Resonance Spectroscopy
81
Irinotecan
79
pembrolizumab
75
Radiation
70
Carboplatin
65
Methotrexate
62
pazopanib
61
Nivolumab
58
Cisplatin
58
fludarabine phosphate
57
Surgical Procedures, Operative
57
Peripheral Blood Stem Cell Transplantation
57
Specimen Handling
56
Trabectedin
52
Docetaxel
50
Biopsy
50
Busulfan
49
Melphalan
46
Paclitaxel
44
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Positron Emission Tomography Computed Tomography
×
Sarcoma
×
Clear all
NCT06726512
2024-12-10
qMAP
University Medical Center Groningen
Phase NA
Not yet recruiting
30 enrolled